NCT06342505View on ClinicalTrials.gov

Tacrolimus in CD3+ T Lymphocytes

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

May 30, 2022

Primary Completion Date

October 10, 2022

Study Completion Date

November 10, 2022

Conditions
Immunosuppression
Interventions
PROCEDURE

Venipunctures

Extra venipunctures

Trial Locations (1)

3015 GD

Erasmus MC, Rotterdam

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER